GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Net Current Asset Value

BDMD (Baird Medical Investment Holdings) Net Current Asset Value : $0.66 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Baird Medical Investment Holdings's net current asset value per share for the quarter that ended in Jun. 2024 was $0.66.

The historical rank and industry rank for Baird Medical Investment Holdings's Net Current Asset Value or its related term are showing as below:

BDMD' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0   Med: 0   Max: 7.85
Current: 7.85

During the past 3 years, the highest Price-to-Net-Current-Asset-Value Ratio of Baird Medical Investment Holdings was 7.85. The lowest was 0.00. And the median was 0.00.

BDMD's Price-to-Net-Current-Asset-Value is ranked worse than
67.78% of 568 companies
in the Medical Devices & Instruments industry
Industry Median: 4.79 vs BDMD: 7.85

Baird Medical Investment Holdings Net Current Asset Value Historical Data

The historical data trend for Baird Medical Investment Holdings's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings Net Current Asset Value Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23
Net Current Asset Value
0.33 0.48 0.54

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
Net Current Asset Value 0.33 0.48 - 0.54 0.66

Competitive Comparison of Baird Medical Investment Holdings's Net Current Asset Value

For the Medical Devices subindustry, Baird Medical Investment Holdings's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baird Medical Investment Holdings's Price-to-Net-Current-Asset-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Baird Medical Investment Holdings's Price-to-Net-Current-Asset-Value falls into.


;
;

Baird Medical Investment Holdings Net Current Asset Value Calculation

Baird Medical Investment Holdings's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(40.083-21.001--0.043-0)/35.450
=0.54

Baird Medical Investment Holdings's Net Current Asset Value (NCAV) per share for the quarter that ended in Jun. 2024 is calculated as

Net Current Asset Value Per Share(Q: Jun. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(46.98-23.75-0.001-0)/35.450
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baird Medical Investment Holdings  (NAS:BDMD) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Baird Medical Investment Holdings Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Baird Medical Investment Holdings Business Description

Traded in Other Exchanges
N/A
Address
No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN
Website
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.